Abstract
In response to the novel coronavirus disease 2019 (CoViD-19) pandemic, national and local institutions have issued public-health orders to slow the spread of the disease. Comparing CoViD-19 trends over time and place may thus provide important public health insights about the impact of different strategies. To aid these comparisons, we illustrate the properties of 3 comparative indicators of CoViD-19 mortality using estimates and projections for the world’s most affected areas. We first demonstrate how a Crude CoViD-19 Death Rate (CCDR) incorporates the temporal dimension of CoViD-19 mortality. We also show how the advantage of the indirectly age-standardized Comparative CoViD-19 Mortality Ratio (CCMR). Finally, we calculate declines in life expectancy at birth that translate CoViD-19 mortality projections into an easily interpretable metric. Projections used to illustrate this yields a .6-year decline in life expectancy at birth for the U.S.A., for instance, which would be twice the largest single-year decline in life expectancy at birth induced by HIV/AIDS (between 1992 and 1993) or the total decline induced by opioid overdoses (between 2014 and 2017). Data about the pandemic are changing too rapidly to draw any conclusion from the current values of the indicators, however, and there are multiple reasons to expect substantial revisions of these projections.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors benefited from facilities and resources provided by the California Center for Population Research at UCLA (CCPR), which receives core support (P2C-HD041022) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data are available online and can be accessed directly or through a web scraping routine that we provide at https://github.com/statsccpr/ind-cov-mort
https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6